Recent Blog Articles

Heart Beat: Generic ARBs are coming

Updated: July 01, 2010

People who take an angiotensin-receptor blocker (ARB) for high blood pressure or other reasons should soon be able to save some money on their medication. The FDA has given the go-ahead for losartan (Cozaar) to be sold as a generic drug. That makes losartan the first generic ARB on the market.

Angiotensin is a protein in the bloodstream that causes blood vessels to contract, which boosts blood pressure. ARBs work by preventing angiotensin from latching onto receptors in blood vessel walls, rendering it unable to deliver the "contract now" message that drives up blood pressure. They work as well as — but not usually better than — the older, less-expensive ACE inhibitors.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.